KLF9 and non-small cell lung carcinoma: Qi et al. (23) found that the abundance of miR-660-5p is enhanced in the plasma and exosomes of non-small cell lung cancer (NSCLC) patients, and miR-660-5p might promote proliferation and metastasis of NSCLC cells by reducing the abundance of KLF9.